Basal insulin for the management of diabetic ketoacidosis
Authors:
- 1 January 2018
- journal article
- review article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 47, 14-16
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Controversies in the management of hyperglycaemic emergencies in adults with diabetesMetabolism, 2017
- Long-Acting Insulin on the Road to Recovery With Diabetic KetoacidosisAmerican Journal of Critical Care, 2016
- A pilot study comparing a protocol using intermittent administration of glargine and regular insulin to a continuous rate infusion of regular insulin in cats with naturally occurring diabetic ketoacidosisJournal of Veterinary Emergency and Critical Care, 2014
- Intramuscular glargine with or without concurrent subcutaneous administration for treatment of feline diabetic ketoacidosisJournal of Veterinary Emergency and Critical Care, 2013
- Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 DiabetesDiabetes Care, 2007
- Insulin GlargineDrugs, 2003
- Management of Hyperglycemic Crises in Patients With DiabetesDiabetes Care, 2001
- Insulin GlargineDrugs, 2001
- Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.Diabetes, 2000
- Hyperglycemic Crises in Urban BlacksArchives of internal medicine (1960), 1997